Daplussi (Sitagliptin, Dapagliflozin)

Daplussi combines sitagliptin and dapagliflozin for oral use, offering a dual-action approach to managing type 2 diabetes. This medication supports blood sugar control and may improve glycemic management.

Daplussi is primarily used to manage type 2 diabetes in adults. It works by increasing insulin production and reducing glucose absorption in the kidneys. This combination therapy is often prescribed when diet and exercise alone are not sufficient. People often ask, 'What is Daplussi used for?' and the answer is it helps control blood sugar levels in type 2 diabetes.

Common effects of Daplussi may include urinary tract infections, hypoglycemia, and gastrointestinal discomfort. Some users experience increased urination due to the dapagliflozin component. It's important to monitor blood sugar levels regularly while using this medication.

Daplussi should be used with caution in patients with a history of kidney disease or pancreatitis. It is essential to stay hydrated and monitor for signs of dehydration. Always consult a healthcare provider before starting this medication.

Daplussi may interact with other medications, including insulin, sulfonylureas, and certain antibiotics. Alcohol consumption should be limited as it can affect blood sugar levels. Always inform your healthcare provider about all medications you are taking.